Denosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients.

Morizio P, Burkhart JI, Ozawa S.

Ann Pharmacother. 2018 Apr 1:1060028018768808. doi:

10.1177/1060028018768808. [Epub ahead of print] PubMed PMID: 29616561.